Opinions+

Opinions+ Justin Norden

Clinical validation will save digital health’s reputation

Opinions+ Sajith Wickramasekara

How to close biopharma’s data science and engineering skills gap

Opinions+ Jeff Levin-Scherz and Andrey Ostrovsky

10 tips for vendors seeking to create or expand digital health and virtual health solutions

Opinions+ Michael J. Alkire and Soumi Saha

How the U.S. can mitigate and prevent medical device shortages

Opinions+ Scott Swain, Kristin M. Zimmerman Savill and Bruce Feinberg

Pharma’s role in value-based care starts with value-based research

Opinions+ Edward M. Kaye

What biotech can learn from past stock market downturns

Opinions+ Abhinav Shashank and Smriti Khera

Biopharma companies need digital portfolios to succeed in a disease management future

Opinions+ Birgit Girshick

Biopharma’s response to the next pandemic depends on collaboration and the ability to learn and fail fast

Opinions+ James Biggins

Med tech companies that approach value-based care contracting wisely can earn first-mover advantage

Opinions+ Jim King and Philip Burton

What’s blocking health care boards’ progress in diversity, equity, and inclusion?

Opinions+ Laurent Levy

Building a better on-ramp for health innovation

Opinions+ Prasad Dindigal

Forget the hype and embrace the reality: How AI can improve health outcomes right now

Opinions+ Elizabeth Ruzzo

8 reasons ‘move fast and break things’ doesn’t work for health care companies

Opinions+ Andy Plump

Maintaining trust in science is crucial to public health. Here’s how the biopharma industry can help

Opinions+ Andrei Iancu and David Kappos

Why does the FDA want to stop improving medicines via patent ‘areas of concern’?

Opinions+ Tom Denwood and Scott Kollins

Rewriting the playbook for digital therapeutics

Opinions+ Andrea Bastek

Combating the burnout bottleneck among clinical research workers

Opinions+ Dawn Anderson

Digital clinical trials can personalize patient engagement, accelerate therapy development

Opinions+ Monique K. Mansoura

A 10-point plan for sustaining the biopharma industrial base for a more secure nation

Opinions+ Chris Plance and Nilesh Chandra

Bringing clarity and consistency to CMS’s hospital price transparency rule will be a win for all

Opinions+ Bret Schiller

Viruses, variants, and the business of health care: Preparing for another wave now and the years ahead

Opinions+ Sam Brown

Human-centered design can boost clinical trial recruitment, retention

Opinions+ Daphne Zohar

Stifling biopharma mergers would kill the innovation economy that generates new therapies

Opinions+ Stephen Ferguson

SARS-CoV-2 brought the world to its knees. Its digital twin is helping bring us back

Opinions+ John Freedman

The many benefits of expanding the reach of state all-payer claims databases